180 related articles for article (PubMed ID: 36607476)
1. Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma.
Takashima Y; Hamano M; Yoshii K; Hayano A; Fukai J; Iwadate Y; Kajiwara K; Hondoh H; Yamanaka R
Int J Clin Oncol; 2023 Mar; 28(3):468-481. PubMed ID: 36607476
[TBL] [Abstract][Full Text] [Related]
2. miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.
Takashima Y; Kawaguchi A; Iwadate Y; Hondoh H; Fukai J; Kajiwara K; Hayano A; Yamanaka R
PLoS One; 2020; 15(2):e0229577. PubMed ID: 32101576
[TBL] [Abstract][Full Text] [Related]
3. Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma.
Takashima Y; Kawaguchi A; Fukai J; Iwadate Y; Kajiwara K; Hondoh H; Yamanaka R
PLoS One; 2021; 16(6):e0251272. PubMed ID: 34166375
[TBL] [Abstract][Full Text] [Related]
4. The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis.
Zhang X; Wu Y; Sun X; Cui Q; Bai X; Dong G; Gao Z; Wang Y; Gao C; Sun S; Ji N; Liu Y
BMC Cancer; 2022 Feb; 22(1):190. PubMed ID: 35184749
[TBL] [Abstract][Full Text] [Related]
5. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
[TBL] [Abstract][Full Text] [Related]
6. The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling.
Alame M; Cornillot E; Cacheux V; Rigau V; Costes-Martineau V; Lacheretz-Szablewski V; Colinge J
Theranostics; 2021; 11(8):3565-3579. PubMed ID: 33664848
[No Abstract] [Full Text] [Related]
7. Sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients.
Fudaba H; Momii Y; Hirakawa T; Onishi K; Asou D; Matsushita W; Kawasaki Y; Sugita K; Fujiki M
Sci Rep; 2021 Jan; 11(1):1206. PubMed ID: 33441719
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
[TBL] [Abstract][Full Text] [Related]
9. Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma.
Kawaguchi A; Iwadate Y; Komohara Y; Sano M; Kajiwara K; Yajima N; Tsuchiya N; Homma J; Aoki H; Kobayashi T; Sakai Y; Hondoh H; Fujii Y; Kakuma T; Yamanaka R
Clin Cancer Res; 2012 Oct; 18(20):5672-81. PubMed ID: 22908096
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
Takashima Y; Kawaguchi A; Iwadate Y; Hondoh H; Fukai J; Kajiwara K; Hayano A; Yamanaka R
PLoS One; 2019; 14(1):e0210400. PubMed ID: 30615673
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL.
Takashima Y; Kawaguchi A; Sato R; Yoshida K; Hayano A; Homma J; Fukai J; Iwadate Y; Kajiwara K; Ishizawa S; Hondoh H; Nakano M; Ogawa S; Tashiro K; Yamanaka R
Sci Rep; 2019 Jul; 9(1):10004. PubMed ID: 31292525
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients.
Yuan X; Yu T; Zhao J; Jiang H; Hao Y; Lei W; Liang Y; Li B; Qian W
Front Med; 2023 Oct; 17(5):889-906. PubMed ID: 37418076
[TBL] [Abstract][Full Text] [Related]
13. Emerging insights into origin and pathobiology of primary central nervous system lymphoma.
You H; Wei L; Kaminska B
Cancer Lett; 2021 Jul; 509():121-129. PubMed ID: 33766752
[TBL] [Abstract][Full Text] [Related]
14. Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma.
Heming M; Haessner S; Wolbert J; Lu IN; Li X; Brokinkel B; Müther M; Holling M; Stummer W; Thomas C; Schulte-Mecklenbeck A; de Faria F; Stoeckius M; Hailfinger S; Lenz G; Kerl K; Wiendl H; Meyer Zu Hörste G; Grauer OM
Genome Med; 2022 Sep; 14(1):109. PubMed ID: 36153593
[TBL] [Abstract][Full Text] [Related]
15. Programmed Cell Death Ligand 1 Expression in Primary Central Nervous System Lymphomas: A Clinicopathological Study.
Hayano A; Komohara Y; Takashima Y; Takeya H; Homma J; Fukai J; Iwadate Y; Kajiwara K; Ishizawa S; Hondoh H; Yamanaka R
Anticancer Res; 2017 Oct; 37(10):5655-5666. PubMed ID: 28982883
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes.
Zhou Y; Liu W; Xu Z; Zhu H; Xiao D; Su W; Zeng R; Feng Y; Duan Y; Zhou J; Zhong M
Neoplasia; 2018 Oct; 20(10):1059-1069. PubMed ID: 30227305
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma.
Furuse M; Kuwabara H; Ikeda N; Hattori Y; Ichikawa T; Kagawa N; Kikuta K; Tamai S; Nakada M; Wakabayashi T; Wanibuchi M; Kuroiwa T; Hirose Y; Miyatake SI
BMC Cancer; 2020 Apr; 20(1):277. PubMed ID: 32248797
[TBL] [Abstract][Full Text] [Related]
18. Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma.
Sung CO; Kim SC; Karnan S; Karube K; Shin HJ; Nam DH; Suh YL; Kim SH; Kim JY; Kim SJ; Kim WS; Seto M; Ko YH
Blood; 2011 Jan; 117(4):1291-300. PubMed ID: 21088137
[TBL] [Abstract][Full Text] [Related]
19. Molecular characteristics of immunocytes infiltration in primary central nervous system lymphoma.
Zhang L; Sun F; Lu X; Wang X; Wang J; Li J; Xu Y; Kou D; Lv H; Don B
Front Genet; 2022; 13():921823. PubMed ID: 36061189
[No Abstract] [Full Text] [Related]
20. Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma.
Sun X; Wang C; Chen C; Huang J; Wu X; Wang Y; He X; Cao J; Jiang W; Sun P; Li Z
Hematol Oncol; 2021 Dec; 39(5):625-638. PubMed ID: 34543472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
